Ebixa 10 mg (Memantine Hydrochloride TABLET) 10 MG

EBIXA 10 MG tablets contain memantine hydrochloride, used to manage moderate to severe Alzheimer's disease symptoms. This oral medication may help improve cognitive function and daily living activities.

Strength

10 MG

Pack Size

Manufacturer / TM Owner

LUNDBECK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EBIXA 10 MG is primarily used to treat moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain, which may help slow the progression of symptoms. People often ask, 'What is EBIXA 10 MG used for?' It is typically prescribed to improve cognitive function, memory, and the ability to perform daily activities.

Side Effects

Common effects of EBIXA 10 MG may include dizziness, headache, and constipation. Some users also report fatigue or confusion. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

EBIXA 10 MG should be handled with care. It is important to follow the prescribed dosage and avoid sudden discontinuation. Patients with certain medical conditions, such as kidney disease, should discuss their health status with a healthcare provider before starting this medication.

Avoid Interactions

EBIXA 10 MG may interact with other medications, including those that affect the central nervous system. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided while taking this medication.

Frequently Asked Questions

EBIXA 10 MG is used to manage symptoms of moderate to severe Alzheimer's disease, helping to improve cognitive function and daily living activities.

EBIXA 10 MG is taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include dizziness, headache, and constipation. Always consult a healthcare provider for personalized advice.

EBIXA 10 MG may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

It is advisable to avoid alcohol consumption while taking EBIXA 10 MG, as it may increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.